This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Yosuke Harada: Innovator in Pancreatic Carcinoma Research
Introduction
Yosuke Harada is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of medical research, particularly in the study of pancreatic carcinoma. His work has implications for diagnosis and treatment, showcasing the importance of genetic research in combating this serious disease.
Latest Patents
Yosuke Harada holds a patent for the TSA305 gene. This invention provides a pancreas-specific gene comprising a base sequence coding for the amino acid sequence shown under SEQ ID NO:1. The gene is particularly effective in the fields of study, diagnosis, and treatment of pancreatic carcinoma.
Career Highlights
Harada is associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and innovations. His work at Otsuka has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
One of his notable coworkers is Kouichi Ozaki. Together, they contribute to the ongoing research and development efforts at Otsuka Pharmaceutical Company.
Conclusion
Yosuke Harada's contributions to the field of pancreatic carcinoma research through his patent on the TSA305 gene highlight the critical role of innovation in medical science. His work continues to pave the way for advancements in diagnosis and treatment options for this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile